These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 37456731)

  • 21. A novel scale-down mimic of perfusion cell culture using sedimentation in an automated microbioreactor (SAM).
    Kreye S; Stahn R; Nawrath K; Goralczyk V; Zoro B; Goletz S
    Biotechnol Prog; 2019 Sep; 35(5):e2832. PubMed ID: 31050211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a novel, high-throughput screening tool for efficient perfusion-based cell culture process development.
    Gagliardi TM; Chelikani R; Yang Y; Tuozzolo G; Yuan H
    Biotechnol Prog; 2019 Jul; 35(4):e2811. PubMed ID: 30932357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A protocol to transfer a fed-batch platform process into semi-perfusion mode: The benefit of automated small-scale bioreactors compared to shake flasks as scale-down model.
    Janoschek S; Schulze M; Zijlstra G; Greller G; Matuszczyk J
    Biotechnol Prog; 2019 Mar; 35(2):e2757. PubMed ID: 30479066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biotherapeutics: Challenges and Opportunities for Predictive Toxicology of Monoclonal Antibodies.
    Johnson DE
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perfusion Cell Culture Decreases Process and Product Heterogeneity in a Head-to-Head Comparison With Fed-Batch.
    Walther J; Lu J; Hollenbach M; Yu M; Hwang C; McLarty J; Brower K
    Biotechnol J; 2019 Feb; 14(2):e1700733. PubMed ID: 29851298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of CHO Metabolism on Cell Growth and Protein Production: An Overview of Toxic and Inhibiting Metabolites and Nutrients.
    Pereira S; Kildegaard HF; Andersen MR
    Biotechnol J; 2018 Mar; 13(3):e1700499. PubMed ID: 29393587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic characterization of a CHO cell size increase phase in fed-batch cultures.
    Pan X; Dalm C; Wijffels RH; Martens DE
    Appl Microbiol Biotechnol; 2017 Nov; 101(22):8101-8113. PubMed ID: 28951949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and control of novel growth inhibitors in fed-batch cultures of Chinese hamster ovary cells.
    Mulukutla BC; Kale J; Kalomeris T; Jacobs M; Hiller GW
    Biotechnol Bioeng; 2017 Aug; 114(8):1779-1790. PubMed ID: 28409820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-controlled hybrid perfusion fed-batch CHO cell process provides significant productivity improvement over conventional fed-batch cultures.
    Hiller GW; Ovalle AM; Gagnon MP; Curran ML; Wang W
    Biotechnol Bioeng; 2017 Jul; 114(7):1438-1447. PubMed ID: 28128436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioreactor productivity and media cost comparison for different intensified cell culture processes.
    Xu S; Gavin J; Jiang R; Chen H
    Biotechnol Prog; 2017 Jul; 33(4):867-878. PubMed ID: 27977910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in intracellular ATP-content of CHO cells as response to hyperosmolality.
    Pfizenmaier J; Matuszczyk JC; Takors R
    Biotechnol Prog; 2015; 31(5):1212-6. PubMed ID: 26146937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins.
    Liu L
    J Pharm Sci; 2015 Jun; 104(6):1866-1884. PubMed ID: 25872915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality.
    Yang WC; Lu J; Kwiatkowski C; Yuan H; Kshirsagar R; Ryll T; Huang YM
    Biotechnol Prog; 2014; 30(3):616-25. PubMed ID: 24574326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell culture process operations for recombinant protein production.
    Abu-Absi S; Xu S; Graham H; Dalal N; Boyer M; Dave K
    Adv Biochem Eng Biotechnol; 2014; 139():35-68. PubMed ID: 24153406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fed-batch and perfusion culture processes: economic, environmental, and operational feasibility under uncertainty.
    Pollock J; Ho SV; Farid SS
    Biotechnol Bioeng; 2013 Jan; 110(1):206-19. PubMed ID: 22806692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated dynamic fed-batch process and media optimization for high productivity cell culture process development.
    Lu F; Toh PC; Burnett I; Li F; Hudson T; Amanullah A; Li J
    Biotechnol Bioeng; 2013 Jan; 110(1):191-205. PubMed ID: 22767053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHO cells in biotechnology for production of recombinant proteins: current state and further potential.
    Kim JY; Kim YG; Lee GM
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):917-30. PubMed ID: 22159888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety and side effects of monoclonal antibodies.
    Hansel TT; Kropshofer H; Singer T; Mitchell JA; George AJ
    Nat Rev Drug Discov; 2010 Apr; 9(4):325-38. PubMed ID: 20305665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between cell size, cell cycle and specific recombinant protein productivity.
    Lloyd DR; Holmes P; Jackson LP; Emery AN; Al-Rubeai M
    Cytotechnology; 2000 Oct; 34(1-2):59-70. PubMed ID: 19003381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization and control of perfusion cultures using a viable cell probe and cell specific perfusion rates.
    Dowd JE; Jubb A; Kwok KE; Piret JM
    Cytotechnology; 2003 May; 42(1):35-45. PubMed ID: 19002926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.